CD8A and neoplasm: In the context of cancer, TCF1 has been mainly studied in CD8+ T cells, where it is linked to a population of stem-like T cells that provides tumor control (Burger et al., 2021; Han et al., 2021; Hanna et al., 2021; Siddiqui et al., 2019).